Table 3 Time between pre- and postoperative MRI, follow-up and time between mastectomy and occurrence of an IBLR or NP
THERAPEUTIC ME INDICATION | PROPHYLACTIC ME INDICATION | ||||
|---|---|---|---|---|---|
NO IBLR or NP (DF-cohort) 87 patients/ 108 breasts | WITH IBLR/NP (D-cohort) 18 patients/ 18 breasts | p-VALUE | NO NP (DF-cohort) 29 patients/ 54 breasts | WITH NP (D-cohort) 1 patient/ 1 breast | |
Time between preoperative and postoperative MRI (median months, IQR)PB | 14.0 (12.0; 19.2) | 25.3 (12.8; 37.7) | .029 | 14.47 (12.96; 22.77) | NA |
Follow-Up (mean months, IQR)PB | 36.9 (19.2; 56.8) | 46.0 (22.8; 81.2) | .249 | 25.38 (16.94; 41.26) | 74.81 |
Time between mastectomy and occurrence of IBLR or NP (median months, IQR)PB | 35.1 (16.0; 57.6) | 33.35 | |||